Publication at First Faculty of Medicine |
2017
Abstract
The ESC/EAS guidelines for the management of dyslipidaemias published in August 2016 represent a large reference document summarizing the development over the five years since the first version was published in 2011. They reflect the knowledge achieved in many areas - from diagnosis and cardiovascular risk stratification to setting therapeutic goals and guiding management to the issue of dyslipidaemias in selected specific groups of patients.
Also discussed are medication adverse effects or the current issue of adherence. The present article highlights selected sections from the comprehensive document by briefly commenting on them.